Brookfield Asset Management Inc. Abb Vie Inc. Transaction History

Brookfield Asset Management Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$132.51 - $164.9 $24.7 Million - $30.8 Million	-186,673 Reduced 67.26%	90,875 $12.2 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $24.7 Million - $30.8 Million	-186,673 Reduced 67.26%	90,875 $12.2 Million
Q1 2023 Sep 25, 2023	BUY	$144.61 - $166.54 $27 Million - $31.1 Million	186,673 Added 205.42%	277,548 $44.2 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $28.9 Million - $33.3 Million	200,077 Added 258.26%	277,548 $44.2 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $10.9 Million - $13.1 Million	-78,780 Reduced 50.42%	77,471 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $21 Million - $24.1 Million	156,251 New	156,251 $21 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $4.92 Million - $6.1 Million	-37,268 Reduced 34.87%	69,609 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $6.12 Million - $7.74 Million	56,921 Added 113.94%	106,877 $14.5 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $3.38 Million - $3.84 Million	31,790 Added 175.0%	49,956 $5.39 Million
Q2 2021 Aug 17, 2021	BUY	$105.21 - $117.21 $1.91 Million - $2.13 Million	18,166 New	18,166 $2.05 Million

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.